Two surgeons, two different recommendations — and why that is a question about the question
Clinical evidence researched September 2026 · Prices researched July 2026
A split recommendation is ordinary, and it almost never means one of the two clinicians is wrong. It means they are answering different questions. There are three kinds — a threshold disagreement, where both see the same number and differ on how much margin they want; a scope disagreement, where “not a candidate” quietly means “not a candidate here”; and a measurement disagreement, where the two centres did not really measure the same cornea — and each one is resolved by something different. Getting the kind right is most of the work. Getting it wrong is how people end up choosing on seniority, on price, or on whoever answered the email fastest.
Three kinds of disagreement, and the resolutions do not transfer
Almost everything written for patients about conflicting advice stops at get a second opinion, which is true and unhelpful, because the thing that makes a second opinion useful is knowing what it is supposed to settle. Before anything else, work out which row of this table you are in.
| Kind | What the two surgeons actually differ on | What resolves it | What does not |
|---|---|---|---|
| Threshold | The same measurements, different margins of acceptable biomechanical risk | Asking each surgeon which margin they apply and why, then deciding whose risk appetite you want | More opinions. You will collect more margins. |
| Scope | What each centre offers, and on what equipment | Asking what you are not a candidate for, and whether a centre with a longer list would answer differently | Seniority. A senior surgeon still answers the narrower question. |
| Measurement | Different instruments produced different numbers from the same eye | A third reading, chosen deliberately to be comparable with one of the first two | A majority vote between two incomparable readings |
The three are not mutually exclusive and a real case often contains two of them at once. They are separated here because the remedies do not transfer: the fix for one is a wasted trip in another.
Threshold: 40 percent and 300 microns are guides, not pass marks
Laser refractive surgery removes tissue, and the central safety question is how much structural margin the cornea retains afterwards. Two figures dominate that conversation and they are both worth knowing by name, because if you know them you can ask a much better question than am I a candidate.
The older of the two is the residual stromal bed — the untouched stromal tissue left beneath a flap and beneath the treatment. A minimum of 250 microns was historically treated as the standard figure; most surgeons now describe 300 microns as the safer one. The newer is percent tissue altered, which takes the expected flap thickness plus the planned ablation depth and divides the sum by the cornea's central thickness. A value above 40 percent has been described as the most significant independent variable associated with post-LASIK ectasia in eyes whose topography looked normal before surgery, and the argument for preferring it over a fixed bed thickness is that it is proportional: it considers the relationship between the cornea you started with, the tissue removed and the bed left behind, rather than a single absolute number. The illustrative case usually given is a very thick cornea from which three quarters is removed — a 250-micron bed is arithmetically intact and biomechanically not reassuring.
The useful consequence for you is a question rather than an answer: ask each surgeon which margin their plan is built on, what the value would be in your case, and what they would want it to be. A centre that can answer that in numbers is a centre that has done the calculation. A centre that cannot is telling you something too.
Measurement: the two clinics may not have measured the same cornea
This is the mechanism that is almost never explained to patients, and it is the one that explains the largest share of the cases we see described. Corneal thickness is not a single objective quantity that every machine reports identically. Different measurement principles produce systematically different numbers on the same eye, and the published comparisons are explicit that the devices are not interchangeable.
- Optical coherence tomography has been reported to yield pachymetry values roughly 10 to 20 microns thicker than Scheimpflug tomography, with the difference attributed to the measurement principles rather than to a fault.
- A direct three-way comparison reported central thickness of about 579 microns on a Sirius system against about 551 on a Pentacam and about 550 by ultrasound, and concluded that pachymetry and keratometry from the two devices should not be used interchangeably.
- Agreement between a Corvis ST and either a Pentacam HR or an OCT device has been described as poor, with differences too large to be considered clinically interchangeable.
- There is a directional tendency as well: a higher assumed corneal refractive index tends to make Scheimpflug devices underestimate central thickness while OCT tends to overestimate it.
Now put that together with the arithmetic from the previous section, because corneal thickness is the denominator of the percent-tissue-altered calculation and the starting point of the residual-bed calculation. A device difference does not stay in the measurement. It propagates into the margin that decides candidacy.
| Same eye, same plan | Measured at 521 µm | Measured at 549 µm |
|---|---|---|
| Planned flap | 110 µm | 110 µm |
| Planned ablation | 100 µm | 100 µm |
| Percent tissue altered (flap + ablation) ÷ thickness | 40.3% — above the 40% line | 38.3% — below it |
| Residual stromal bed | 311 µm — clears a 300 floor | 339 µm — clears a 300 floor |
| Verdict under a 40% tissue-altered ceiling | Declined | Offered |
This is a worked illustration of a mechanism, not a statement about any real eye and not a calculation you should perform on your own numbers. The flap and ablation figures are ordinary round numbers chosen to sit near the threshold; the 28-micron spread between the two thickness columns is the size of the gap reported between two commercial devices measuring the same eyes. Percent tissue altered and residual bed are published screening concepts, not criteria applied to you here. Candidacy is determined by the operating surgeon after the full workup.
Read that table again and notice what it does not show: a mistake. Two centres, two respectable machines, one honest calculation each, and opposite conclusions. It also shows why the instinctive remedy fails. If you respond to this disagreement by collecting a third opinion at random, you are likely to collect a third instrument as well, and three incomparable numbers are not more decisive than two. The fix for a measurement disagreement is a reading you have deliberately made comparable — the same device type as one of the first two, or a repeat on the machine that produced the outlying figure — and a surgeon who has been asked to comment on the existing plans rather than to generate a fresh one.
What the numbers on those reports mean, line by line, is a separate subject and we keep it on a page of its own. The question here is narrower and it is about provenance: which machine produced this, and is it comparable with the other one.
Scope: “not a candidate” often means “not a candidate here”
A refusal feels like a fact about your eyes. Sometimes it is. Often it is a fact about the intersection of your eyes with one clinic's list of procedures, and the two are worth prising apart before you accept either.
A centre that performs flap-based LASIK and lenticule extraction can tell you that you are not a candidate for flap-based LASIK or lenticule extraction. It cannot tell you that surface ablation is unavailable to you, and it may not be the right place to ask about an implantable lens. Equipment narrows scope in ways that are entirely legitimate and rarely stated: a laser platform that does not carry a particular treatment profile, a lens range that does not stock a particular size, a surgeon who does not personally perform a procedure the hospital advertises. None of that is concealment. It is simply not what the word no sounds like when you hear it.
The question that separates the two. Not “am I a candidate” but “what am I not a candidate for, which measurement drove that, and would a centre offering a wider range of procedures reach the same conclusion?” A refusal that survives those three is telling you about your cornea. A refusal that dissolves under them was telling you about the clinic. If what is driving the refusal turns out to be a suspect topographic pattern rather than a margin, that is a finding rather than a judgement and it is covered separately in what a suspect cornea does to a refractive plan.
The screening scores themselves disagree, and their published performance says so
It would be convenient if there were a validated score that settled these cases, and there are scores — but their own literature describes them disagreeing with outcomes often enough that a surgeon's decision not to rely on one is a defensible position rather than an eccentricity.
External analyses of the best-known ectasia risk scoring system report sensitivity in classifying high-risk cases of around 56 percent in one review of post-LASIK ectasia cases, and around 70 percent sensitivity against roughly 50 percent specificity in another sample — a system that misses a substantial share of the patients it is meant to flag while also flagging many who would have been fine. Part of the explanation offered is methodological: the original derivation rested on a single central ultrasound reading and anterior curvature analysis, which is an incomplete picture next to a three-dimensional tomographic reconstruction of both corneal surfaces and the full pachymetric spatial profile.
So a surgeon screening with a risk score and a surgeon screening with modern tomographic indices are not being more and less careful than one another. They are running different instruments with different published error profiles, and on a borderline cornea those instruments can legitimately part company. If you want one question to ask about this, it is: what did you screen with, and what does it miss?
Why seniority is the worst tiebreak available to you
When two answers conflict and nothing else distinguishes them, almost everyone reaches for the same heuristic: trust the more senior surgeon, or the larger hospital, or the longer list of publications. It is a reasonable instinct and it addresses only one of the three disagreements.
| Kind of disagreement | Does seniority help? |
|---|---|
| Threshold | Partly, yes. How much biomechanical margin to require on a case like yours is exactly the kind of judgement that experience and case volume inform. Weigh it — but it is still a reason to ask more, not a reason to stop. |
| Scope | No. A surgeon at a centre that does not offer the procedure in question is answering the narrower question however senior they are. Thirty years does not widen a procedure list. |
| Measurement | No. Seniority does not adjudicate between two machines. A comparable third reading does. |
The pattern worth naming, because it comes up repeatedly in the questions travellers actually ask: what decides a split recommendation is the asymmetry between the two assessments, not the rank of the two assessors. Find the asymmetry first — different machine, different procedure list, different margin — and the seniority question usually turns out to have been the wrong question.
The cross-border form of this problem, which is the part no domestic page covers
Everything above applies equally to someone choosing between two clinics in their own city. One thing does not, and it is the reason this page exists on a site about travelling to China for surgery.
A second opinion obtained after you have flown is not a second opinion. It is a delay you are paying for. At home, resolving a split recommendation costs an appointment and a drive across town, and the worst case is a fortnight. Once you have landed, the same resolution is spent out of a fixed trip window: hotel nights you are already paying for, possibly a change fee on a return flight, annual leave that does not extend, and the live possibility that the procedure does not happen on this trip at all while the airfare is already gone.
| Where the disagreement surfaces | What resolving it costs you |
|---|---|
| Before booking | Emails, and at most one scan at home. The cheapest place this problem can possibly be. |
| After booking, before flying | Emails plus whatever your flight and hotel change terms are. Still recoverable. |
| At the workup, after arrival | Days inside the trip window, a second consultation fee, and the real chance of flying home unoperated with the travel spent. |
This is not an argument for rushing a decision — the opposite. It is an argument for having the disagreement early, in writing, while it is cheap, which means asking the measurement and scope questions above by email before you commit to dates. If you are planning the trip itself around this, our page on how long to stay sets out the ordinary windows, and the one on being turned down at the workup covers what happens when a single centre says no after you arrive — which is a different situation from this one, because that is one answer and this page is about two.
What to collect from each clinic, in the order that makes a remote second opinion possible
The single most common reason a second opinion fails to resolve anything is that the patient brought conclusions instead of data. Ask for these, from both centres, before the email thread goes cold.
- The make and model of the device that measured your cornea. First on the list, because a thickness without an instrument attached cannot be compared with anything.
- Central corneal thickness and the thinnest-point thickness, with the location of the thinnest point.
- Keratometry readings, including the steepest value.
- The topography or tomography images themselves, not a one-line summary. A second surgeon reads the map; the summary is already an interpretation.
- The refraction the plan is based on, and whether it was taken with dilating drops. Two centres working from different refractions will propose different treatments for reasons that have nothing to do with the cornea.
- The planned flap thickness and how the flap would be made, or the equivalent for a lenticule or surface treatment.
- The planned ablation or lenticule depth.
- Percent tissue altered and residual stromal bed the plan would leave, if the centre computes them. Many do; asking also tells you whether this centre thinks in those terms.
- The date of each measurement, and whether you had worn contact lenses beforehand — and if so, which type and how recently. A measurement taken on a cornea that has not washed out is a different measurement.
What a split recommendation does to the money
Two plans frequently mean two prices, and the gap can be large enough to become an argument in its own right. It should not be. Price is a consequence of the clinical reasoning, and when it starts doing the deciding the disagreement has quietly been resolved by the wrong authority.
| Procedure | China, standard rate | Where it usually sits in a split recommendation |
|---|---|---|
| TransPRK | $1,000–1,500 | Frequently the reroute when a flap is the objection but the margin is otherwise workable |
| LASIK | $1,200–1,800 | The plan most often declined on a tissue-altered or residual-bed margin, because the flap enters both calculations |
| SMILE | $2,200–2,900 | Often the second of two laser proposals; a split between this and LASIK is usually a trade-off discussion, not a candidacy one |
| EVO ICL | $3,800–4,800 | The usual destination when the disagreement ends in “no tissue should be removed” |
Standard rates researched July 2026 and consistent with the ranges published on our home page. Ranges move, hospitals price individually, and a quotation for your eyes can only be produced after a workup. Full breakdowns: what LASIK costs in China, what SMILE costs and what EVO ICL costs.
Two implications worth stating. First, a split that ends in a lens plan roughly triples the laser price, so a surgeon recommending the more expensive route is not thereby suspect — that is where the reasoning leads when tissue removal is the objection. Second, and more often missed: a split recommendation has its own cost even if you never change procedure, in consultation fees, a repeat scan, and time. Budget a few hundred dollars and a fortnight for resolving it properly at home. It is the cheapest money in this entire process.
Six questions that turn a disagreement into a decision
- Which machine measured my cornea, and what thickness did it give? Ask both centres. If the makes differ, you have found a measurement disagreement.
- What margin is your plan built on — a residual bed figure, a percent tissue altered ceiling, or something else — and what is my value?
- What am I not a candidate for, specifically, and what drove that? For the centre that declined.
- Would a centre offering a wider range of procedures be likely to reach a different conclusion about this cornea? A straight answer here is informative about more than your eyes.
- What would have to be different about my eyes for you to recommend the other procedure? Ask both. The answers usually expose whether the difference is about your cornea or about the clinic's habits.
- What is the main disadvantage of the procedure you are recommending? A surgeon who can name one is easier to trust on the rest.
None of those six asks anyone to justify themselves, and that is deliberate. They ask each surgeon to make their reasoning visible, which is a request a good one will be glad to meet. The point is not to catch anybody out. It is that you are the only person in this situation who is talking to both of them, and the comparison is therefore yours to make and nobody else's to make for you.
Questions people actually ask
Two surgeons gave me different recommendations. Does that mean one of them is wrong?
Usually not, and starting from the assumption that one of them must be wrong is what makes the situation hard to resolve. Refractive surgery has very few genuine pass marks. It has margins, and a margin is a judgement about how much risk is acceptable, made by a named person who will carry the consequence. The two best-known margins in laser surgery are a residual stromal bed — the untouched tissue left beneath the treatment — and percent tissue altered, which is the flap thickness plus the planned ablation depth divided by the cornea's central thickness. A residual bed of 250 microns was historically treated as the floor and many surgeons now prefer 300 as the safer figure, and a percent tissue altered above 40 percent has been described as the most robust single risk factor for ectasia after LASIK in eyes whose topography looked normal beforehand. Those are not the same test, they do not always agree on the same eye, and both are defensible. So two careful surgeons can look at one cornea, apply different margins, and reach opposite conclusions without either being careless or dishonest. What you are looking at is not an error to be caught. It is a difference you have to understand well enough to choose between.
Why would the same cornea produce two different corneal thickness numbers?
Because the two clinics probably did not measure it with the same kind of machine, and the published comparisons say the machines are not interchangeable. Optical coherence tomography has been reported to return central corneal thickness values roughly 10 to 20 microns thicker than Scheimpflug tomography, and the reviews attribute that to the different measurement principles rather than to one device being faulty. Direct device comparisons show the same pattern at a larger scale: one study reported pachymetry of about 579 microns on a Sirius system against about 551 on a Pentacam and about 550 by ultrasound, on the same eyes, and concluded that the two devices' pachymetry and keratometry should not be used interchangeably. Agreement between a Corvis ST and either a Pentacam HR or an OCT device has been described as poor, with differences too large to be clinically interchangeable. None of that is a scandal; it is the ordinary state of corneal metrology. It matters to you because corneal thickness is the denominator of the percent-tissue-altered calculation and the starting point of the residual-bed calculation, so a difference between devices propagates straight into the margin that decides your candidacy.
Can a difference between two machines actually change the verdict, or is it too small to matter?
On a comfortable eye it changes nothing, and on a borderline eye it can change everything, which is precisely why borderline eyes are where split recommendations cluster. Work the arithmetic with published figures rather than with adjectives. Take a planned flap of 110 microns and a planned ablation of 100 microns — 210 microns of altered tissue. Divide that by a central corneal thickness of 521 microns and percent tissue altered is 40.3 percent, which sits on the wrong side of the 40 percent line. Divide the identical treatment by 549 microns — a 28-micron difference, the size of the gap reported between two commercial devices on the same eyes — and it is 38.3 percent, on the right side. The residual bed, meanwhile, reads 311 microns on one figure and 339 on the other, so it clears a 300-micron floor either way. One eye, one treatment plan, and depending on which machine measured it and which margin the surgeon applies, it fails one test and passes the other. That is a worked illustration of a mechanism, not a statement about your eyes. The point of showing it is that the fix for this kind of disagreement is a third measurement on a named device, not a vote between the first two.
Does 'you are not a candidate' mean I am not a candidate anywhere?
It might, and it might mean something much narrower, and the two are worth separating before you accept either. A refusal is often a scope statement rather than a verdict on your eyes: a centre that offers three procedures can only tell you that you are not a candidate for those three. A centre down the road offering five — surface ablation, a different laser platform, a phakic lens — is answering a larger question and can reach a different conclusion about the same cornea without contradicting anyone. Equipment is part of scope too. A hospital whose excimer platform does not carry a particular treatment profile, or that does not stock a particular lens size, has a real reason to decline that has nothing to do with your biology. So the question to put back is not whether you are a candidate but what you are not a candidate for, on what measurement, and whether the answer would change at a centre with a different list of procedures. A refusal that survives that question is telling you something about your eyes. A refusal that does not is telling you something about the clinic.
Should I go with the more senior surgeon, or the bigger hospital?
Seniority is the most tempting tiebreak and the least informative one, because it does not address what the two surgeons actually differ about. If the disagreement is a scope disagreement, the more senior surgeon at a centre that does not offer the procedure in question is still answering the narrower question, and thirty years of experience does not widen it. If it is a measurement disagreement, seniority does not adjudicate between two machines; a third reading does. Seniority is genuinely relevant to exactly one of the three cases — a threshold judgement, where a surgeon is deciding how much biomechanical margin they want on a case like yours, and volume and experience are part of how that judgement is formed. Even there it is a reason to weigh an opinion, not a reason to stop asking. The practical move is to identify which kind of disagreement you are in first, because in two of the three cases the seniority question is simply the wrong question and answering it feels like progress while producing none.
Can I just get a third opinion and take two out of three?
A third opinion is often the right move and majority voting is almost always the wrong way to use it. If two centres measured your cornea on different device types, a third centre measuring on yet another one does not break the tie, it adds a third number to a set that was never going to converge by counting. What helps is a third assessment that is deliberately designed to resolve the specific disagreement: the same device type as one of the first two so the readings are comparable, or a repeat on the machine that produced the outlying figure, or an explicit request that the third surgeon comment on the other two plans rather than generate a fresh one. Bring the raw data with you, not the conclusions. And if two of the three agree only because two of the three used the same instrument, you have not got a majority, you have got one measurement counted twice. The value of the third opinion is in what it explains, not in what it outvotes.
What should I collect from each clinic so a second opinion is actually possible?
Ask for the data, not the recommendation, and ask before you leave the building or the email thread goes cold. The minimum useful set is: the make and model of the device that measured your cornea, because a number without an instrument attached cannot be compared to anything; the central corneal thickness and the thinnest-point thickness with their location; the keratometry readings including the steepest value; the full topography or tomography images rather than a summary sheet; the refraction the plan is based on and whether it was taken with dilating drops; the planned flap thickness and how the flap would be made; the planned ablation depth; and, if the centre computes it, the percent tissue altered and the residual stromal bed the plan would leave. Two more that travellers forget: the date of each measurement, and whether you were wearing contact lenses in the period before it. A second opinion built on a summary sheet is an opinion about a summary sheet. A second opinion built on the images and the raw numbers is an opinion about your eyes.
Is it safer to just follow whichever surgeon is more conservative?
Defaulting to the more cautious plan is a reasonable instinct and it is not automatically the safer decision, because conservatism has costs that are easy to leave out of the comparison. Declining laser surgery on a cornea with a slim margin genuinely avoids a biomechanical risk. Being rerouted to an intraocular lens moves you to a different procedure with a different risk profile, not to a risk-free one, and it roughly triples the price on our own dated ranges. Doing nothing keeps you in glasses or contact lenses, which is a perfectly good outcome that some people are glad of and others find has its own costs. So the honest framing is not cautious versus reckless but which set of trade-offs you would rather hold, given that you are the one who holds them afterwards. Where the conservative view does deserve extra weight is when it rests on a finding rather than on a preference — a suspect topographic pattern, an unstable refraction, a documented change over time. A finding is evidence. A margin is a judgement. Ask which one you are being given.
Can I sort the disagreement out after I arrive in China?
You can, and it is the most expensive place to do it, which is the single difference between your situation and that of a patient choosing between two clinics in their own city. At home, a second opinion costs an appointment and a drive. After you have flown, the same second opinion costs hotel nights inside a fixed trip window, possibly a change fee on a return flight, and the risk that the procedure does not happen on this trip at all — while the airfare is already spent. The asymmetry is worth stating plainly: resolving a split recommendation before departure costs emails and perhaps a scan at home; resolving it after arrival costs days you have already paid for. That is why the document list above is a pre-departure list rather than a packing list. It is also why a centre that answers specific measurement questions clearly by email before you book is giving you information about more than your cornea. None of this is a reason to rush a decision; it is a reason to have the disagreement early, where it is cheap.
What if the disagreement is between two procedures rather than between yes and no?
Then you are usually in the most tractable version of this situation, because both surgeons have said yes and what remains is a trade-off you are entitled to weigh yourself. A split between a flap-based treatment, a lenticule extraction, a surface ablation and an implantable lens is frequently a split about which downside matters most: corneal biomechanics, recovery speed, dry-eye tendency, reversibility, the dioptric range a platform is comfortable with, or simply which procedure that centre performs most often. Ask each surgeon the same two questions — what would have to be different about my eyes for you to recommend the other procedure, and what is the main disadvantage of the one you are recommending — and the answers usually expose whether the difference is about your cornea or about the clinic's habits. Compare on the specifics rather than on the totals: on our dated ranges the gap between a laser plan and a lens plan is several thousand dollars, and a price difference that large deserves to be a consequence of the clinical reasoning rather than the reason for it. Which procedure is appropriate is determined by the operating surgeon after the workup; which set of trade-offs you prefer is not a medical question at all.